These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 26606302

  • 1. Cytotechnologist Performance for Screening Hürthle Cell Atypia in Indeterminate Thyroid Fine-Needle Aspirates.
    VandenBussche CJ, Adams C, Ali SZ, Olson MT.
    Acta Cytol; 2015; 59(5):377-83. PubMed ID: 26606302
    [Abstract] [Full Text] [Related]

  • 2. Cytotechnologist performance for screening microfollicular atypia in indeterminate thyroid fine-needle aspirates.
    VandenBussche CJ, Olson MT, Adams C, Ali SZ.
    Acta Cytol; 2014; 58(5):432-8. PubMed ID: 25341367
    [Abstract] [Full Text] [Related]

  • 3. The prevalence and surgical outcomes of Hürthle cell lesions in FNAs of the thyroid: A multi-institutional study in 6 Asian countries.
    Agarwal S, Bychkov A, Jung CK, Hirokawa M, Lai CR, Hong S, Kwon HJ, Rangdaeng S, Liu Z, Su P, Kakudo K, Jain D.
    Cancer Cytopathol; 2019 Mar; 127(3):181-191. PubMed ID: 30668897
    [Abstract] [Full Text] [Related]

  • 4. Malignancy risk for solitary and multiple nodules in Hürthle cell-predominant thyroid fine-needle aspirations: A multi-institutional study.
    Wong KS, Jo VY, Lowe AC, Faquin WC, Renshaw AA, Shah AA, Roh MH, Stelow EB, Krane JF.
    Cancer Cytopathol; 2020 Jan; 128(1):68-75. PubMed ID: 31751003
    [Abstract] [Full Text] [Related]

  • 5. Risk of Malignancy and Risk of Neoplasia in the Bethesda Indeterminate Categories: Study on 4,532 Thyroid Fine-Needle Aspirations from a Single Institution in India.
    Mahajan S, Srinivasan R, Rajwanshi A, Radotra B, Panda N, Dey P, Gupta N, Nijhawan R.
    Acta Cytol; 2017 Jan; 61(2):103-110. PubMed ID: 28407624
    [Abstract] [Full Text] [Related]

  • 6. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT, Yang J, Wasserman PG, Bhuiya T, Griffith KA, Michael CW.
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [Abstract] [Full Text] [Related]

  • 7. Malignancy risk and reproducibility associated with atypia of undetermined significance on thyroid cytology.
    Mathur A, Najafian A, Schneider EB, Zeiger MA, Olson MT.
    Surgery; 2014 Dec; 156(6):1471-6; discussion1476. PubMed ID: 25218896
    [Abstract] [Full Text] [Related]

  • 8. Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology.
    Yazgan A, Balci S, Dincer N, Kiyak G, Tuzun D, Ersoy R, Cakir B, Guler G.
    Cytopathology; 2014 Jun; 25(3):185-9. PubMed ID: 24024935
    [Abstract] [Full Text] [Related]

  • 9. Performance of the Afirma Gene Expression Classifier in Hürthle Cell Thyroid Nodules Differs from Other Indeterminate Thyroid Nodules.
    Brauner E, Holmes BJ, Krane JF, Nishino M, Zurakowski D, Hennessey JV, Faquin WC, Parangi S.
    Thyroid; 2015 Jul; 25(7):789-96. PubMed ID: 25962906
    [Abstract] [Full Text] [Related]

  • 10. Cytotechnologist performance for detecting nuclear atypia in indeterminate thyroid fine needle aspirates.
    VandenBussche CJ, Adams C, Ali SZ, Olson MT.
    Acta Cytol; 2014 Jul; 58(3):239-47. PubMed ID: 24943222
    [Abstract] [Full Text] [Related]

  • 11. Hürthle cell lesions on thyroid fine needle aspiration cytology: Molecular and histologic correlation.
    Schatz-Siemers N, Brandler TC, Oweity T, Sun W, Hernandez A, Levine P.
    Diagn Cytopathol; 2019 Oct; 47(10):977-985. PubMed ID: 31293091
    [Abstract] [Full Text] [Related]

  • 12. Impact of specific patterns on the sensitivity for follicular and Hurthle cell carcinoma in thyroid fine-needle aspiration.
    Renshaw AA, Gould EW.
    Cancer Cytopathol; 2016 Oct; 124(10):729-736. PubMed ID: 27322887
    [Abstract] [Full Text] [Related]

  • 13. Hurthle cells in fine needle aspiration cytology of the thyroid: a potential diagnostic dilemma?
    Wong YP, Md Isa N, Md Zin RR, Noor Akmal S.
    Malays J Pathol; 2015 Apr; 37(1):49-52. PubMed ID: 25890614
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hürthle cell neoplasms diagnosed by fine needle aspiration are not associated with an increased risk of malignancy.
    McKee S, Wu H, Wang X, Cramer H, Lin J, Chen S.
    Acta Cytol; 2014 Apr; 58(3):235-8. PubMed ID: 24819535
    [Abstract] [Full Text] [Related]

  • 16. Sonographically suspicious thyroid nodules with initially benign cytologic results: the role of a core needle biopsy.
    Ha EJ, Baek JH, Lee JH, Song DE, Kim JK, Shong YK, Hong SJ.
    Thyroid; 2013 Jun; 23(6):703-8. PubMed ID: 23544697
    [Abstract] [Full Text] [Related]

  • 17. The impact of atypia/follicular lesion of undetermined significance on the rate of malignancy in thyroid fine-needle aspiration: evaluation of the Bethesda System for Reporting Thyroid Cytopathology.
    Broome JT, Solorzano CC.
    Surgery; 2011 Dec; 150(6):1234-41. PubMed ID: 22136846
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.
    Hyeon J, Ahn S, Shin JH, Oh YL.
    Cancer Cytopathol; 2014 May; 122(5):368-76. PubMed ID: 24591408
    [Abstract] [Full Text] [Related]

  • 20. Fine-needle aspiration biopsy specimen with a predominance of Hürthle cells: a dilemma in the management of nodular thyroid disease.
    Alaedeen DI, Khiyami A, McHenry CR.
    Surgery; 2005 Oct; 138(4):650-6; discussion 656-7. PubMed ID: 16269293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.